| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |